```html

Extremity Deep Vein Thrombosis (DVT) – A Patient‑Friendly Guide

Overview

Deep vein thrombosis (DVT) is the formation of a blood clot (thrombus) in a deep vein, most commonly in the lower‑leg or thigh veins, but it can also occur in the upper extremities (arms). When we speak of “extremity DVT,” we refer to clots that develop in the deep veins of the arms or legs.

• Who it affects: Adults of any age, but incidence rises sharply after age 45. Women are slightly more likely to develop upper‑extremity DVT because of catheter use and hormonal factors.
• Prevalence: In the United States, an estimated 600,000–900,000 people develop DVT each year, and 1–2 % of those have upper‑extremity involvement.<sup>1</sup> Worldwide, VTE (venous thromboembolism, which includes DVT and pulmonary embolism) affects 1–2 per 1,000 people annually.<sup>2</sup>

Because clots can dislodge and travel to the lungs, DVT is a medical emergency if not recognized and treated promptly.

Symptoms

Symptoms can be subtle, especially in the arms. Any new, unexplained changes in a limb should prompt evaluation.

Typical lower‑extremity signs

• Pain or cramping: Often described as a deep ache, tenderness, or a “charley horse” feeling, usually in the calf or thigh.
• Swelling (edema): The affected leg may appear larger than the other; swelling can develop gradually over hours‑to‑days.
• Warmth & redness: The skin may feel warmer to the touch and look reddish or bluish.
• Visible veins: Superficial veins may become more prominent as deep veins enlarge.

Upper‑extremity (arm) signs

• Pain or heaviness: Often reported in the shoulder, upper arm, or forearm, worsening with arm elevation.
• Swelling: Usually localized to the hand and forearm; may cause a feeling of tightness.
• Discoloration: Bluish or purplish hue of the skin.
• Reduced range of motion: Stiffness and difficulty performing daily tasks.

Symptoms that may indicate clot extension or embolization

• Sudden shortness of breath, chest pain, or coughing up blood (signs of pulmonary embolism).
• Rapid heartbeat, light‑headedness, or fainting.

Causes and Risk Factors

DVT results from a combination of three elements known as **Virchow’s triad**:

1. Stasis of blood flow – e.g., prolonged immobility.
2. Endothelial injury – damage to the inner vein lining.
3. Hypercoagulability – increased tendency of blood to clot.

Common causes

• Prolonged inactivity: Long flights, car trips, or bed rest after surgery.
• Central venous catheters or PICC lines: Frequently placed in the subclavian or brachial veins for chemotherapy, antibiotics, or parenteral nutrition – a leading cause of upper‑extremity DVT.
• Trauma or surgery: Orthopedic procedures on the hip/knee or shoulder surgery.
• Pregnancy & postpartum period: Hormonal changes and venous compression by the uterus.
• Hormone therapy: Oral contraceptives, estrogen replacement, or testosterone therapy.
• Inherited clotting disorders: Factor V Leiden, prothrombin G20210A mutation, protein C/S deficiency.
• Cancer: Malignancy (especially pancreatic, lung, ovarian) and chemotherapy increase clot risk.
• Obesity: BMI ≥ 30 kg/m² raises venous pressure.
• Chronic medical conditions: Heart failure, inflammatory bowel disease, nephrotic syndrome.

Who is at highest risk?

Risk Factor	Relative Risk Increase
Major orthopedic surgery (hip/knee)	2–5 ×
Active cancer	4–7 ×
Recent prolonged travel (>4 h)	1.5–2 ×
Central venous catheter	5–10 × for upper‑extremity DVT
Inherited thrombophilia	2–6 ×

Diagnosis

Timely diagnosis relies on a combination of clinical assessment, risk‑factor evaluation, and imaging.

Clinical prediction tools

• Wells Score for DVT – Assigns points for signs (e.g., calf swelling) and risk factors. A score ≤0 suggests low probability; ≥2 indicates moderate‑to‑high probability.
• D‑dimer test – High sensitivity; a negative result virtually rules out DVT in low‑risk patients.

Imaging studies

1. Compression duplex ultrasonography – First‑line, non‑invasive test. Operator applies gentle pressure; veins that do not compress suggest a clot.
2. Venography – Contrast‑enhanced X‑ray; rarely used now because ultrasound is highly accurate.
3. Magnetic resonance venography (MRV) or CT venography – Helpful for pelvic or upper‑extremity veins that are difficult to image with ultrasound.

Laboratory tests

• D‑dimer – Elevated in clot breakdown; useful for ruling out DVT in low‑risk settings.
• Coagulation panel – PT/INR, aPTT, platelet count, especially before starting anticoagulation.
• Thrombophilia screen – Consider in young patients with unprovoked DVT or recurrent events.

Treatment Options

The goals of therapy are to prevent clot extension, reduce the risk of pulmonary embolism (PE), and limit long‑term complications such as post‑thrombotic syndrome.

Anticoagulant medications

Drug Class	Examples	Typical Duration
Direct oral anticoagulants (DOACs)	Apixaban, Rivaroxaban, Edoxaban, Dabigatran	3–12 months (adjust per risk)
Low‑molecular‑weight heparin (LMWH)	Enoxaparin, Dalteparin	Initial 5–10 days, then transition to oral agents
Unfractionated heparin (UFH)	IV infusion – used when rapid reversal may be needed	5–7 days (bridge to oral)
Vitamin K antagonists (VKAs)	Warfarin (target INR 2.0–3.0)	3–12 months; longer if persistent risk

DOACs are now first‑line for most patients without contraindications because they require no routine lab monitoring and have a lower bleeding risk compared with warfarin.<sup>3</sup>

Procedural interventions

• Catheter‑directed thrombolysis: Instills clot‑dissolving medication directly into the thrombus; considered for extensive proximal DVT or severe symptoms.
• Pharmacomechanical thrombectomy: Mechanical removal plus low‑dose thrombolytics; may improve vein patency.
• Inferior vena cava (IVC) filter: Placed in the IVC to catch emboli; reserved for patients who cannot be anticoagulated or have recurrent PE despite therapy.
• Compression therapy: Graduated elastic stockings (20‑30 mmHg) reduce swelling and post‑thrombotic syndrome; start after the acute phase.

Lifestyle and adjunct measures

• Early ambulation after surgery or hospitalization.
• Leg‑raising or arm‑elevation to facilitate venous return.
• Hydration—adequate fluid intake reduces blood viscosity.

Living with Extremity Deep Vein Thrombosis

Adapting daily life helps prevent recurrence and minimizes discomfort.

Medication adherence

• Take anticoagulants exactly as prescribed; set daily reminders.
• Inform any new healthcare provider (dentist, surgeon) that you are on anticoagulation.

Activity and exercise

• Walk 5‑10 minutes every hour during prolonged sitting.
• Gentle calf‑pump or arm‑pump exercises (flex/extend ankle or wrist) improve venous flow.
• Avoid high‑impact sports during the first 2 weeks unless cleared by your doctor.

Compression garments

• Wear prescribed stockings or sleeves for at least 2 years to lower the risk of post‑thrombotic syndrome.
• Measure leg/arm circumference correctly; have them fitted by a trained professional.

Monitoring & follow‑up

• First follow‑up visit 1–2 weeks after starting anticoagulation, then every 3 months while on therapy.
• Report new leg swelling, unexplained bruising, or bleeding (gums, urine, stool).
• Keep a simple log of symptoms and medication side‑effects.

Travel tips

• Move or stretch every 1–2 hours on long flights or car trips.
• Consider wearing compression stockings during travel.
• Stay hydrated and avoid excessive alcohol.

Prevention

Prevention strategies vary by setting (hospital vs. community) and individual risk.

General measures

• Maintain a healthy weight (BMI < 30 kg/m²).
• Quit smoking – smoking doubles VTE risk.
• Regular physical activity (≥150 min moderate‑intensity/week).
• Stay well‑hydrated, especially in hot climates or during long travel.

Medical prophylaxis

• Post‑operative: LMWH or DOACs for 10–35 days after major orthopedic surgery, per ACCP guidelines.<sup>4</sup>
• Hospitalized medical patients: Low‑dose LMWH, fondaparinux, or intermittent pneumatic compression devices.
• Patients with indwelling catheters: Use the smallest caliber catheter possible; remove as soon as clinically feasible.
• Pregnant women: Compression stockings and, in high‑risk cases, prophylactic LMWH.

Home‑based prevention

• Elevate legs when seated for >30 minutes.
• Avoid crossing legs for prolonged periods.
• Perform “ankle circles” and “toe‑taps” while sitting.

Complications

If left untreated or inadequately managed, extremity DVT can lead to serious short‑ and long‑term problems.

Acute complications

• Pulmonary embolism (PE): The clot breaks free, travels to pulmonary arteries; can be fatal.
• Phlegmasia cerulea dolens: Massive venous outflow obstruction causing severe pain, cyanosis, and possible limb loss.

Chronic complications

• Post‑thrombotic syndrome (PTS): Persistent swelling, pain, skin discoloration, and ulceration; occurs in up to 30‑50 % of lower‑extremity DVT patients.<sup>5</sup>
• Recurrent DVT: Prior clot increases future risk by 2–3 ×.
• Venous insufficiency: Damaged valves lead to chronic edema and varicose veins.

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. Venous Thromboembolism (VTE) Statistics. Updated 2023.
2. World Health Organization. Fact sheet: Venous thromboembolism. 2022.
3. American College of Cardiology/American Heart Association. 2022 ACC/AHA Guideline on the Management of VTE.
4. American College of Chest Physicians. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. 2021.
5. Huang L, et al. Post‑thrombotic syndrome after deep vein thrombosis: a systematic review. Blood Reviews. 2021;45:100755.

```